Requests for Specimen Verification will only be accepted from May 15 to July 15, 2020. If you plan to submit a grant application this cycle, an approved Request for Specimen Verification is required. Once your Request for Specimen Verification has been approved, you will receive a confirmation letter to accompany your grant application.

The grant application deadline is August 11, 2020.

Information is available regarding the PLCO trial and PLCO biospecimens

Please visit the PAR Request Form for Specimen Verification page to preview instructions about the process, review the Policies and Procedures, and begin a Request for Specimen Verification.

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

Preliminary applications will only be accepted from February 24 to August 17, 2020. If you plan to submit an EEMS application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application.

The full application deadline is October 1, 2020. The full applications will undergo panel review and final outcome notifications will be sent in early December 2020.

Information is available regarding the PLCO trial and PLCO biospecimens.

Please visit the EEMS Application for Biospecimens page to preview instructions about the process, review the EEMS Policies and Procedures, and begin an EEMS Preliminary Application for Biospecimens.

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

Preliminary applications will only be accepted from February 20 to August 7, 2020. If you plan to submit an IDATA Biospecimen application this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application.

The full application deadline is September 14, 2020. The full applications will undergo panel review and final outcome notifications will be sent by mid-November 2020.

Information is available regarding the IDATA study and IDATA biospecimens.

Please visit the IDATA Application for Biospecimens page to preview instructions about the process, review the IDATA Biospecimen Policies and Procedures, and begin an IDATA Preliminary Application for Biospecimens.

If you have any questions, please contact CDAS staff at cdas-idatabio@imsweb.com

The National Cancer Institute is happy to announce the availability of data for the following trials:

• MAY2012: Colon/Linaclotide
• MDA10-16-01: Breast/DHA
• UAZ2013-01-01: Nasal Tissue/Acetylsalicylic Acid
• UWI10-16-01R: Full Body/9cUAB30

You can learn more about these trials at cdas.cancer.gov/eppt/ and request access to the data at cdas.cancer.gov/learn/eppt/instructions/.

As of Tuesday, October 15, the Cancer Data Access System has completed the move to its new home at: cdas.cancer.gov.

All web pages from the previous location (biometry.nci.nih.gov/cdas) should automatically redirect to the same page at the new url. If you have any questions, please contact us at: cdas@imsweb.com